Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. NC3640435

BPS Bioscience Inc SBE Luciferase Reporter Lentivirus, 2 vials, 500 μl each, TGFβ/SMAD signaling pathway, Firefly Luciferase, ≥5 x 10^6 TU/ml, -80°C storage
SDP

Catalog No. NC3640435
Encompass

The SBE Luciferase Reporter Lentivirus is engineered to facilitate the monitoring of the TGFβ/SMAD signaling pathway. This replication-incompetent lentiviral particle, utilizing HIV-based and VSV-G pseudotyping technology, incorporates a firefly luciferase gene regulated by a multimerized SBE-responsive element. It offers a sensitive method for detecting changes in the TGFβ/SMAD pathway activity in mammalian cells. This product serves as an essential tool for those aiming to screen potential pathway modulators and develop stable reporter cell lines.

Catalog No. NC3640435 Supplier BPS Bioscience Inc Supplier No. 79806
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

The SBE Luciferase Reporter Lentivirus is engineered to facilitate the monitoring of the TGFβ/SMAD signaling pathway. This replication-incompetent lentiviral particle, utilizing HIV-based and VSV-G pseudotyping technology, incorporates a firefly luciferase gene regulated by a multimerized SBE-responsive element. It offers a sensitive method for detecting changes in the TGFβ/SMAD pathway activity in mammalian cells. This product serves as an essential tool for those aiming to screen potential pathway modulators and develop stable reporter cell lines.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.